<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Institute for Research and Community Services Universitas Muhammadiyah Palangkaraya</journal-id>
      <journal-id journal-id-type="publisher-id">.</journal-id>
      <journal-title>Institute for Research and Community Services Universitas Muhammadiyah Palangkaraya</journal-title><issn pub-type="ppub">2621-4814</issn><issn pub-type="epub">2621-4814</issn><publisher>
      	<publisher-name>Institute for Research and Community Services Universitas Muhammadiyah Palangkaraya</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="doi">10.33084/bjop.v5i2.3363</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Research Article</subject>
        </subj-group>
        <subj-group><subject>campylobacter</subject><subject>campylobacteriosis</subject><subject>microbial risk assessment</subject><subject>source attribution</subject><subject>bacterial pathogens</subject></subj-group>
      </article-categories>
      <title-group>
        <article-title>Campylobacter Species, Microbiological Source Tracking and Risk Assessment of Bacterial pathogens</article-title><subtitle>Campylobacter Species, Microbiological Source Tracking and Risk Assessment of Bacterial pathogens</subtitle></title-group>
      <contrib-group><contrib contrib-type="author">
	<name name-style="western">
	<surname>Gulumbe</surname>
		<given-names>Bashar Haruna</given-names>
	</name>
	<aff>Department of Microbiology, Federal University Birnin Kebbi, Birnin Kebbi, Kebbi State, Nigeria</aff>
	</contrib><contrib contrib-type="author">
	<name name-style="western">
	<surname>Bazata</surname>
		<given-names>Abbas Yusuf</given-names>
	</name>
	<aff>Department of Microbiology, Federal University Birnin Kebbi, Birnin Kebbi, Kebbi State, Nigeria</aff>
	</contrib><contrib contrib-type="author">
	<name name-style="western">
	<surname>Bagwai</surname>
		<given-names>Musbahu Abdullahi</given-names>
	</name>
	<aff>Department of Life Sciences, Kano State Polytechnic, Kano, Kano State, Nigeria</aff>
	</contrib></contrib-group>		
      <pub-date pub-type="ppub">
        <month>05</month>
        <year>2022</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>31</day>
        <month>05</month>
        <year>2022</year>
      </pub-date>
      <volume>5</volume>
      <issue>2</issue>
      <permissions>
        <copyright-statement>© 2022 Bashar Haruna Gulumbe, Abbas Yusuf Bazata, Musbahu Abdullahi Bagwai</copyright-statement>
        <copyright-year>2022</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-sa/4.0/"><p>This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.</p></license>
      </permissions>
      <related-article related-article-type="companion" vol="2" page="e235" id="RA1" ext-link-type="pmc">
			<article-title>Campylobacter Species, Microbiological Source Tracking and Risk Assessment of Bacterial pathogens</article-title>
      </related-article>
	  <abstract abstract-type="toc">
		<p>
			Campylobacter species continue to remain critical pathogens of public health interest. They are responsible for approximately 500 million cases of gastroenteritis per year worldwide. Infection occurs through the consumption of contaminated food and water. Microbial risk assessment and source tracking are crucial epidemiological strategies to monitor the outbreak of campylobacteriosis effectively. Various methods have been proposed for microbial source tracking and risk assessment, most of which rely on conventional microbiological techniques such as detecting fecal indicator organisms and other novel microbial source tracking methods, including library-dependent microbial source tracking and library-independent source tracking approaches. However, both the traditional and novel methods have their setbacks. For example, while the conventional techniques are associated with a poor correlation between indicator organism and pathogen presence, on the other hand, it is impractical to interpret qPCR-generated markers to establish the exact human health risks even though it can give information regarding the potential source and relative human risk. Therefore, this article provides up-to-date information on campylobacteriosis, various approaches for source attribution, and risk assessment of bacterial pathogens, including next-generation sequencing approaches such as shotgun metagenomics, which effectively answer the questions of potential pathogens are there and in what quantities.
		</p>
		</abstract>
    </article-meta>
  </front>
  <body><sec>
			<title>INTRODUCTION</title>
				<p >Campylobacter spp cause campylobacteriosis, a chronic enteric infection.
Campylobacter spp. are among the leading causes of gastroenteritis
globally<bold>1</bold>. Importantly, World
Health
Organization
(WHO) has identified Campylobacter species as one of the
high-priority antimicrobial resistance. The evolution of antimicrobial
resistance poses an additional threat to modern medical procedures, rendering
current intervention measures geared towards curtailing the menace ineffective
and increasing the mortality rate, causing treatment failure and infections—the
spread of resistance genes through the environment<bold>2</bold>. Although the environment has been described as the reservoir of
antibiotic-resistant bacteria which can be transmitted to humans, the
environmental load of antibiotic-resistant Campylobacter is scarcely
investigated<bold>3</bold>. Ingestion of contaminated water, as well as food, is the principal risk
factor of campylobacteriosis<bold>4</bold>.</p><p >There are
various methods of source tracking and microbial risk assessment, most of which
rely on conventional microbiological techniques. Detection of fecal indicator
organisms such as Escherichia coli has been used as a traditional
surface water pollution monitoring and risk assessment method<bold>5</bold>. However, this method is hampered by several limitations: poor correlation
between indicator organism and pathogen presence and the inability of the
method to indicate the source of fecal pollution since indicator organisms are
excreted by some warm-blooded animals, although source tracking is an essential
tool for public health risk characterization and the subsequent implementation
of remediation and control strategies<bold>6</bold><bold>-</bold><bold>8</bold>. In the last few years, novel microbial source tracking methods have
emerged to mitigate these challenges. These include library-dependent microbial
source tracking and library-independent source tracking. However,
library-dependent microbial source tracking methods have several setbacks, such
as poor interspecies sensitivity, specificity, and overall accuracy<bold>9</bold>. Interestingly, library-independent techniques such as quantitative PCR
(qPCR) have allowed the accurate study of fecal pollutants in environmental
samples, including water, by quantifying the host-specific microbial source by tracking
gene markers<bold>10</bold>. In the library, independent techniques, Bacteroidales, as bacteria
with a strict requirement for the absence of oxygen inhabiting the human and
animal gut with a higher population relative to E. coli, are typically
used as the target<bold>11</bold>. Host-specific Bacteroidales 16S rRNA gene markers have been
developed for diverse hosts to segregate human and non-human fecal sources in
the environment<bold>12</bold>. However, instead of targeting Bacteroidales 16S rRNA, a recent
study reports that bird feces could be discriminated from other fecal sources
by targeting bacterial taxonomic groups like species of Helicobacter
with better results<bold>13</bold>. Again, these methods are not without limitations. For example, studies
have reported that variations in geographical locations could seriously
interfere with the performance and results of these microbial source tracking
techniques<bold>14</bold><bold>,</bold><bold>15</bold>. Equally, it is impractical to interpret qPCR-generated molecular markers
to establish the exact human health risks even though it can give information
regarding the potential source and relative human risk<bold>16</bold>. Other techniques of microbial source tracing depend on the results of
antibiotics resistance and carbon utilization assays<bold>17</bold>. In light of the limitations of these methods, it is, therefore, necessary
to look inward to find alternative options that are robust in terms of
sensitivity and specificity. </p><p >Recent
advances in next-generation sequencing (NGS) approaches (<bold>Figure 1</bold>), such as shotgun metagenomic sequencing, have resulted in its widespread
application in every aspect of microbiology, microbial source tracking
inclusive<bold>18</bold>. Shotgun metagenomics can effectively answer the questions of what
potential pathogens are there in a sample by identifying virulence and
resistance genes and in what quantities<bold>19</bold>. When analyzed using an appropriate source tracking algorism, shotgun
metagenomics data becomes a powerful tool for microbial source tracking and
risk assessment<bold>20</bold>.</p><p >Shotgun
metagenomics is widely applied in environmental and clinical studies<bold>21</bold>. Metagenomics sequencing has been used to systematically study antibiotic
genes associated with the human microbiome<bold>22</bold>, study the links of the microbiome with inflammatory bowel diseases<bold>23</bold>, and, importantly, track outbreaks of human pathogens<bold>24</bold>. Therefore, we set out to provide information on various source
attribution methods and risk assessment of bacterial pathogens, highlighting
the potential of next-generation sequencing in combination with machine
learning technology.</p><table-wrap><label>Table</label><table>
    <tr>
     <td>
     
     Metagenomic
     analysis
     
     </td>
    </tr>
   </table></table-wrap><table-wrap><label>Table</label><table>
    <tr>
     <td>
     
     16S rRNA gene
     sequencing
     
     </td>
    </tr>
   </table></table-wrap><table-wrap><label>Table</label><table>
    <tr>
     <td>
     
     Shotgun
     metagenomic sequencing
     
     </td>
    </tr>
   </table></table-wrap><table-wrap><label>Table</label><table>
    <tr>
     <td>
     
     Whole genome
     sequencing
     
     </td>
    </tr>
   </table></table-wrap><table-wrap><label>Table</label><table>
    <tr>
     <td>
     
     Sequenced genome
     (s)
     
     </td>
    </tr>
   </table></table-wrap><table-wrap><label>Table</label><table>
    <tr>
     <td>
     
     Genome-scale
     metabolic model
     
     </td>
    </tr>
   </table></table-wrap><table-wrap><label>Table</label><table>
    <tr>
     <td>
     
     Predictive
     metagenomic profiling
     
     </td>
    </tr>
   </table></table-wrap><table-wrap><label>Table</label><table>
    <tr>
     <td>
     
     Predictive of
     the abundance of functional gene families present in microbial communities
     
     </td>
    </tr>
   </table></table-wrap><table-wrap><label>Table</label><table>
    <tr>
     <td>
     
     Microbiological
     risk assessment
     
     </td>
    </tr>
   </table></table-wrap><table-wrap><label>Table</label><table>
    <tr>
     <td>
     
     What can they
     potentially do?
     
     </td>
    </tr>
   </table></table-wrap><table-wrap><label>Table</label><table>
    <tr>
     <td>
     
     Who is there?
     
     </td>
    </tr>
   </table></table-wrap><table-wrap><label>Table</label><table>
    <tr>
     <td>
     
     Taxonomic
     composition
     
     </td>
    </tr>
   </table></table-wrap><table-wrap><label>Table</label><table>
    <tr>
     <td>
     
     Functional potential
     
     </td>
    </tr>
   </table></table-wrap><p ><bold>Figure</bold><bold>1</bold><bold>.</bold> The links between
metagenomics and microbial risk assessment<bold>25</bold></p>
			</sec><sec>
			<title>MEDICALLY IMPORTANT Campylobacter spp., RESISTANCE GENES, AND RESERVOIRS</title>
				<p >Campylobacter species,
gram-negative, slender, spirally curled, and microaerophilic bacteria are
essential etiologic agents of gastroenteritis in humans, responsible for
approximately 500 million cases of gastroenteritis per year globally<bold>1</bold>. Veron and
Chatelain<bold>26</bold> were the first to
carry out a broad taxonomic study on the Campylobacter genus and
classified them into four different species: C. fetus, C. coli, C. jejuni,
and C. sputorum nearly five decades ago. Ever since, at least 36 species
and 14 subspecies of Campylobacter have been described<bold>27</bold>. These include C.
upsaliensis, C. ureolyticus, C. helveticus, C. rectus, C. showae, C. gracilis,
C. hominis, C. curvus, C. concisus, C. insulaenigrae, C. hyointestinalis,
and C. lanienae. Of all these, C. jejuni and C. coli are
considered to be the leading cause of human campylobacteriosis<bold>27</bold><bold>,</bold><bold>28</bold>. Various extra-gastrointestinal
conditions and autoimmune diseases, especially Guillain–Barre syndrome, have
been mainly linked to C. jejuni<bold>27</bold>. However,
pathogenicity in other species such as C. lari, C. fetus, C. ureolyticus, C.
upsaliensis, C. hyointestinalis, and C. concisus has been documented<bold>29</bold><bold>,</bold><bold>30</bold>. Species of C.
fetus have been isolated in septicemia patients and are frequently
described as the etiologic agent of poor fertility and miscarriage in humans
and animals<bold>27</bold>. It is therefore
clear that the accurate tracking of these pathogens is crucial given their
wide-ranging medical significance, especially as a number of them have been
identified to harbor antibiotic resistance genes (<bold>Table I</bold>).</p><p ><bold>Tab</bold><bold>le</bold><bold>I</bold><bold>.</bold> Medically important Campylobacter spp., resistance genes, and
reservoirs</p><table-wrap><label>Table</label><table>
 <tr>
  <td>
  Campylobacter spp.
  </td>
  
  <td>
  Resistance
  genes
  </td>
  
  <td>
  Primary
  reservoir
  </td>
  
  <td>
  References
  </td>
  
 </tr>
 <tr>
  <td>
  C. jejuni
  </td>
  
  <td>
  CmeDEF, erm(B), aadE, sat4, aphA-3, tet(O), ant-like A, ant-like B, ant(6)-Ia, sat-1, sat-4,
  lnuC, ant(6)-Ib, aad9, aph(3)-IIIa, aph(2)-IIIa, hpt, apmA, blaOXA-61, gyrA and CmeABC
  </td>
  
  <td>
  Dogs
  and cats 
  </td>
  
  <td>
  27,31-35
  </td>
  
 </tr>
 <tr>
  <td>
  C. coli
  </td>
  
  <td>
  erm(B), CmeABC, aadE,
  sat4, aphA-3, tet(O), blaOXA-61, cat, cfr(C), gyrA, ant-like A, ant-like
  B, ant(6)-Ia, sat-1, sat-4, lnuC, ant(6)-Ib, aad9, aph(3)-IIIa, aph(2)-IIIa, hpt,
  apmA and lnuCs
  </td>
  
  <td>
  Dogs,
  cats, pigs and poultry 
  </td>
  
  <td>
  27,31,33-37
  </td>
  
 </tr>
 <tr>
  <td>
  C. upsaliensis
  </td>
  
  <td>
  tet(O) and gyrA
  </td>
  
  <td>
  Dogs
  and cats 
  </td>
  
  <td>
  38,39
  </td>
  
 </tr>
 <tr>
  <td>
  C. fetus subsp. fetus 
  </td>
  
  <td>
  gyrA, tet(44) and ant(6)-Ib
  </td>
  
  <td>
  Cattle
  and sheep
  </td>
  
  <td>
  40,41
  </td>
  
 </tr>
 <tr>
  <td>
  C. rectus
  </td>
  
  <td>
  erm(B)
  </td>
  
  <td>
  Human oral cavity
  and dogs
  </td>
  
  <td>
  42-44
  </td>
  
 </tr>
 <tr>
  <td>
  C. hyointestinalis
  </td>
  
  <td>
  gyrA
  </td>
  
  <td>
  Cattle,
  pig and sheep
  </td>
  
  <td>
  44,45
  </td>
  
 </tr>
</table></table-wrap><p >Campylobacter jejuni and C. coli
exhibit intrinsic resistance to bacitracin, novobiocin, penicillin, rifampicin,
trimethoprim, sulfamethoxazole, vancomycin, and most of the cephalosporins,
whereas resistance to aminoglycosides, quinolones, macrolides, ketolides,
amphenicols, and tetracyclines is usually acquired<bold>46</bold><bold>-</bold><bold>48</bold>. Although
macrolides, such as azithromycin, and fluoroquinolone, such as ciprofloxacin,
are the primary and secondary drugs of choice for the treatment of
campylobacteriosis, resistance to these important antibiotics among species of Campylobacter
with the potential to bring about more severe consequences, including
prolonging hospitalization and higher risk of invasive infection or even death,
have been reported<bold>27</bold>. This is of
enormous concern, particularly when the global public health experts are
struggling to contain the menace of antimicrobial resistance. What is more
concerning, though, is that various mechanisms of resistance and, in some
cases, a combination of more than one mechanism have been identified in these
pathogens<bold>49</bold>. <bold>Table II</bold> summarizes the
various mechanisms of resistance identified in Campylobacter spp.</p>
			</sec><sec>
			<title>MICROBIAL RISK ASSESSMENT</title>
				<p >Quantitative
microbial risk assessment modeling has been used to evaluate the risk of
disease from waterborne pathogens since the 1980s. It is a type of modeling
used to outline the human risk of exposure to disease-causing microbes from the
environment through a dose-response model<bold>50</bold>. These models
consist of several probability steps that rely on literature or primary data.
Before the 2010 Haiti cholera epidemic, only a few studies, such as an analysis
of the 1993 cryptosporidium outbreak in Milwaukee, Wisconsin, and an analysis
of epidemic and endemic conditions caused by waterborne pathogens, applied
mathematical modeling to study the transmission of the etiologic agents<bold>51</bold><bold>,</bold><bold>52</bold>. However, the Haiti
cholera epidemic shattered the country in 2010 and triggered a significant
interest in applying infectious disease transmission modeling methods for
waterborne microbial risk assessment; ever since significant progress has been
made<bold>53</bold>.</p><p ><bold>Tab</bold><bold>le</bold><bold>II</bold><bold>.</bold> Campylobacter
spp. mechanisms of resistance to various classes of antibiotics</p><table-wrap><label>Table</label><table>
 <tr>
  <td>
  Class
  of antibiotic
  </td>
  
  <td>
  Mechanism
  of antibiotic resistance
  </td>
  
  <td>
  References
  </td>
  
 </tr>
 <tr>
  <td>
  Aminoglycosides
  such as gentamicin,
  amikacin, tobramycin, neomycin, and streptomycin.
  </td>
  
  <td>
  a). Enzymatic
  modification and inactivation of antibiotics
  </td>
  
  <td>
  27,54
  </td>
  
 </tr>
 <tr>
  <td>
  Macrolides,
  lincosamides and ketolides. Examples include erythromycin, roxithromycin,
  azithromycin and clarithromycin.
  </td>
  
  <td>
  a). Target mutation
  in 23S rRNA or/and ribosomal proteins L4 and L22
  b). Modification of
  the ribosomal target by methylation through erm(B)
  c). Multidrug
  efflux pump (CmeABC) and altered membrane permeability
  </td>
  
  <td>
  55,56
  </td>
  
 </tr>
 <tr>
  <td>
  Quinolones such as levofloxacin (Levaquin),
  ciprofloxacin (Cipro), ciprofloxacin extended-release tablets, moxifloxacin
  (Avelox), ofloxacin, gemifloxacin (Factive) and delafloxacin (Baxdela)
  </td>
  
  <td>
  a). Modification of
  DNA gyrase target (Thr86Ile)
  b). Multidrug
  efflux pump (CmeABC)
  </td>
  
  <td>
  27,57
  </td>
  
 </tr>
 <tr>
  <td>
  Tetracyclines such
  as tetracycline,
  doxycycline, minocycline and tigecycline
  </td>
  
  <td>
  a). Protection of
  the ribosomal binding site by ribosomal protection proteins (RPPs) encoded by
  tet(O)
  b). Multidrug
  efflux pump (CmeABC)
  </td>
  
  <td>
  58,59
  </td>
  
 </tr>
 <tr>
  <td>
  β-Lactam
  antibiotics (penicillins and cephalosporins) such as carbenicillin, penicillin G, ticarcillin, ampicillin,
  nafcillin, cloxacillin, mezlocillin, oxacillin, and piperacillin.
  </td>
  
  <td>
  a). Enzymatic
  inactivation of the antimicrobials by β-lactamase (OXA-61)
  b). Multidrug
  efflux pump (CmeABC)
  </td>
  
  <td>
  27,60
  </td>
  
 </tr>
</table></table-wrap><p >Dose-response models
are response curves produced by plotting the probability of a response outcome
such as infection, illness, or death versus the known dose of the etiologic
agent via an identified transmission route. Dose-response model is the main
component of quantitative microbial risk assessment<bold>61</bold>. It is so crucial
that a complete quantitative microbial risk assessment model is almost
impossible to develop without it. Dose-response modeling can be regarded as a
multidisciplinary area requiring substantial knowledge and skills in
microbiology, pathology, mathematics, statistics, and computing<bold>62</bold>. In order to
understand the procedure employed in the development and delivery of inoculum,
as well as assess the employability of the data to the dose-response model,
microbiology skills are necessary<bold>63</bold>.</p><p >On the other hand,
knowledge of pathology is required to assess the relevance and setbacks of
identified exposure routes. To understand how to develop approaches to improve
a model and write the required code to run such algorithms, computing and
mathematics skills are needed. Furthermore, statistics knowledge is necessary
for determining the confidence associated with employing the dose-response
model across multiple hosts, pathogen strains, pathogen isolates, and routes of
exposure<bold>64</bold>. In the design of a
dose-response model, dosing experiments are typically carried out on animal
models. Here a fixed concentration of pathogens is introduced to animals, and
the resulting response is observed. The outcomes obtained are then incorporated
into exponential or β-Poisson models, which will produce numerical constants
that would calculate the probability of response outcome possible. Pathogen’s
concentration needed to trigger a response in ½ of the tested population would
be regarded as either lethal dose-50 (LD50) or infectious dose-50
(ID50)<bold>61</bold>.</p><p >The dose-response
models currently available in quantitative microbial risk assessment software
packages are fixed, based on the pathogen(s) chosen or sole pathogen(s). The
packages do not make it possible for researchers to choose a dose-response
model or learn more about dose-response modeling in general, hindering users’
ability to visualize and optimize the dose-response model<bold>65</bold>. For example,
QMRASpot, a quantitative microbial risk assessment software developed by Kiwa
Watercycle Research (KWR) which precisely models drinking water systems for the
Dutch government, has its overall exposure pathway and dose-response models
embedded, unchangeable, and cannot be independently visualized<bold>66</bold>. Similarly, The
FDA-iRISK, an integrative comparative risk assessment system primarily designed
for food-borne hazards, displays the dose-response model name and its
functional forms. It also updates the dose-response model regularly using
expert elicitation from dose-response experts, but the capability to choose,
optimize or visualize the dose-response models is unavailable<bold>67</bold>. Noteworthy,
dose-response models for many infectious bacteria, including
antibiotic-resistant bacteria, are lacking, and whether dose-response between
antibiotic-resistant and susceptible bacteria might vary remains unknown. Therefore,
to bypass these limitations associated with dose-response models<bold>61</bold>.</p>
			</sec><sec>
			<title>APPLICATION OF SHOTGUN METAGENOMICS AND MATHEMATICAL MODELS IN RISK ASSESSMENT</title>
				<p >Application of
high-throughput sequencing techniques such as shotgun metagenomics can allow
genomic analyses and identification of genes present in genomes of all
microbial communities and the protein in a sample without the need for prior culture
in the laboratory<bold>68</bold>. Shotgun
metagenomic sequencing is a type of sequencing that reads out the nucleotide
bases of all microbial DNA present in a sample without targeting a particular
genomic locus<bold>69</bold>. Here, microbial
DNA is typically extracted and pruned into small chunks sequenced severally
rather than targeting a specific genomic locus. This will produce DNA reads
that align to distinct genomic locations for the various genomes present in the
sample. This approach allows resistance and virulence genes to be identified, cloned,
and functionally expressed<bold>70</bold>. In comparison to
16S rRNA gene amplicon sequencing, which only profiles targeted organisms or
particular genes, shotgun metagenomics sequencing has been proven to provide
results with enhanced resolution, better sensitivity, and more broad
characterization of microbial communities in samples. This has led to its
widespread application across the globe in various fields of scientific
research<bold>71</bold>.</p><p >Since its
introduction almost two decades ago, metagenomics approaches have been applied
to various studies, including characterizing endosymbiotic bacteria from the
environment, identification of bacterial species capable of carrying out total
ammonia nitrification, detecting of presence of antibiotic-resistant genes in
bacteria from the gut, investigating human pathogen outbreak and study of
diversity and function of microorganisms living in different types of water
samples<bold>72</bold>. Specifically,
shotgun metagenomics has been employed to characterize taxonomic and functional
shifts in hot water microbiomes and established that unassembled short
metagenomic reads were efficient for broadly screening for the potential
presence and quantities of pathogens of interest in water<bold>73</bold>. Likewise, in a
recent study, Chen et al.<bold>74</bold> carried outsource
the identification of antibiotic resistance genes of an interconnected
river-lake system using shotgun metagenomics and observed an abundance of
assorted genes linked to sewage pollution from city effluents. Further, in a
different study<bold>75</bold>, a shotgun
metagenomic study brings sand from freshwater beaches as a source of
disease-causing bacteria. Hence, the exploitation of this approach in microbial
risk assessment no doubt offers significant potential in discovering resistance
and virulence genes among members of Campylobacter in the water
system. </p><p >Targeted screening
method using the 16S rRNA gene marker for bacteria and shotgun metagenomics
approach, which allows for the broad-range simultaneous detection of all
microorganisms using the complete genetic information in the sample, are the
two classical approaches commonly employed to study the composition of
metagenomics samples<bold>76</bold>. The 16S rRNA gene,
found in the genetic material of every bacterium, has alternating and conserved
regions. The conserved areas of the 16S rRNA gene allow for amplifying the nine
variable regions using specific short single-strands of nucleic acid called primers.
The amplification products are then processed for sequencing in a library
construction process<bold>77</bold>. Typically, shotgun
metagenomics constitutes six steps from study design to data validation. There
is sample collection; processing and sequencing; pre-processing of the
sequencing reads; profiling of taxonomic, functional, and genomic features; and
data analysis<bold>78</bold>. Every stage of
this multi-sequential requires careful preparation and excursion, especially
since every step has several pitfalls that can affect the final result. To
ensure the lysis reagent has access to the nucleic acid, adequate
homogenization, and cell lysis before nucleic acid extraction must be achieved<bold>79</bold>.</p><p >Phylogenetic
analyses of pathogenic microbes using next-generation sequencing approaches
like shotgun metagenomics are potent tools for tracking the origin of disease,
examining the evolutionary relationships, and deciphering the transmission
pathways<bold>69</bold>. Shotgun
metagenomics is so robust that it can be employed in taxonomic characterization
and understanding the relationships between microorganisms, their activities,
and functionalities in a given environment. This way, interest can be in the
presence of antibiotic resistance and virulence genes and their transcripts<bold>80</bold>. Using an
appropriate bioinformatics analysis tool or microbial risk assessment model,
data generated from shotgun metagenomics can be analyzed to investigate an
outbreak, source attribution, and risk assessment, depending on the study's
objectives. Therefore, the potential this kind of powerful approach holds
cannot be overlooked<bold>81</bold>.</p>
			</sec><sec>
			<title>APPLICATION OF WHOLE GENOME SEQUENCING AND METAGENOMICS IN OUTBREAK INVESTIGATION, SOURCE ATTRIBUTION AND RISK ASSESSMENT OF FOODBORNE PATHOGENS</title>
				<p >Whole genome
sequencing (WGS) and metagenomics are powerful tools in contemporary food
safety studies because they make possible robust and timely detection,
identification, and characterization of a wide range of foodborne pathogens.
During an outbreak, a credible, rapid and powerful identification technique is
invaluable in curtailing the etiologic agent's further spread and avoiding false
source attribution<bold>82</bold>. Either
culture-based or targeted techniques commonly identify foodborne pathogens.
Targeted identification techniques such as PCR or ELISA, although rapid since
they can be carried out without the need for prior culture, are not potent and
therefore allow unrepresentative strains to go undetected. In addition, because
of their low molecular level resolution, these techniques are incapable of
establishing the link between an outbreak and detected pathogenic
microorganisms<bold>83</bold>.</p><p >In recent years, the
development of novel source-tracking models has been rapidly triggered by a
surge in the application of WGS in food safety and public health. Various
models and machine learning algorithms have now replaced conventional risk
assessment models. Bioinformatics data sharing tools make it particularly
crucial as it allows efficient use of WGS and metagenomics in risk assessment,
source tracking, and outbreak investigations, specifically at local, regional,
national, and international levels<bold>84</bold>. Whole genome
sequencing is a powerful molecular technique with a high ability to
discriminate among isolates. Thus, it can be employed to establish the
relationship between an outbreak and a specific pathogen. Although its
laborious nature has limited its application to research settings rather than
routine food screening, quite several researchers have successfully employed
WGS for source tracking in retro-perspective studies of enterohemorrhagic E.
coli<bold>85</bold>, Salmonella Bareilly
strain causing a foodborne outbreak<bold>86</bold>, and protracted
invasive listeriosis Outbreak in Germany<bold>87</bold>.</p><p >Further, the use of
WGS in outbreak investigation in the food industry by the United States Food
and Drug Administration and the Centre for Disease Control is increasing. For
the outbreak investigation, data generated from WGS studies are deposited to
the GenomeTrakr, an open-access database. Currently, the GenomeTrakr database
consists of laboratories in the US and worldwide, resulting in a significant
data increase<bold>88</bold>. GenomeTrakr and
similar databases employed in outbreak investigations are making it
increasingly possible to decipher the links between sequence data from disease outbreaks
on the one hand and food and environmental sources on the other. Similarly, the
capacity of WGS to discriminate isolates based on their sources makes it
possible to detect diffuse outbreaks by linking rare cases, which would
ordinarily be regarded as sporadic cases lacking a common source. This will go
a long way in mitigating disease outbreaks from their source<bold>89</bold>.</p><p >Phylogenetic data
can be employed in source attribution since source attribution aims to measure
the corresponding significance of particular food sources and animal reservoirs
for human cases of foodborne diseases. The genetic information could indicate
possible relationships with specific hosts or reservoirs and therefore provide
hints on a particular foodborne path's geographical distribution and
transmission path<bold>90</bold>. In identifying
transmission routes by determining the epidemiological links between reservoirs
or sources of infections and supplanting the epidemiological data, WGS is an
efficient technique. This approach has proven efficient for several foodborne
pathogens such as Salmonella, replacing traditional source tracking
methods, which are often insufficient and inaccurately attribute the source of
contamination<bold>91</bold>. Metagenomics, as a
technique that does not rely on a prior culture of samples, has the potential
to contribute significantly to outbreak investigation, and risk assessment in
food microbiology, particularly as it relates to the detection and
characterization of non-culturable, fastidious microbes, the source attribution
of risk related to virulence and resistance genes, as well as assessment of
microbial risk in complex communities<bold>82</bold>.</p><p >The application of
metagenomics sequencing makes it possible for the synchronous detection and
identification of the etiologic agent, antimicrobial resistance, and virulence
genes, providing potential as a reliable technique for examining food and water
quality<bold>92</bold>. The application of
metagenomics in food safety to detect pathogenic microorganisms in foods is one
major area that has received attention in recent years. In addition to
detection and identification, analysis such as source attribution and risk
quantification might be desired. The pathogenicity of some food pathogens, such
as the Bacillus cereus, which have very similar genomes, can be
determined using virulence determinants encoded on their extrachromosomal DNA.
The combination of data such as the presence of pathogens and specific
virulence markers is necessary for risk assessment associated with these
bacteria in contaminated food<bold>82</bold>. In order to detect
foodborne pathogens using metagenomics, the application of shotgun sequencing
has been recommended since it allows the detection and characterization of
microorganisms from various forms of samples<bold>93</bold>.</p><p >Using the
metagenomics approach, detection of disease-causing bacteria involves taxonomic
profiling of shotgun sequencing data using bioinformatics tools which could
produce false results, especially at the species level. This could bring about
the detection of less pathogenic or opportunistic pathogens rather than human
pathogens, leading to underestimation or overestimation of the potential risk.
It is, therefore, necessary to verify results<bold>94</bold>. Moreover,
species-level identification is inadequate in assessing the potential risk of
foodborne pathogens. Thus, it is necessary to determine virulence and
resistance genes<bold>95</bold>. One other problem
of taxonomic classification using metagenomics in risk assessment is that it
detects hundreds of species of organisms, including those not of health
significance, in a sample. Therefore, to detect species pertinent to risk
assessment, it is indispensable to target pathogens, thence effortlessly
removing trivial data for risk assessment. Doing this will no doubt minimize
one of the major challenges of metagenomic studies, the difficulties associated
with data analysis<bold>96</bold>.</p><p >For risk assessment
in food samples using metagenomic analysis, Grützke et al.<bold>97</bold> proposed a workflow
in which the first identification of taxonomic units with kraken2 using the
complete RefSeq database. Then from the list of species, human, animal, or
plant pathogens are filtered, classified reads are extracted from the
metagenomic dataset and verified with BLAST using the nucleotide database from
the website of the National Center for Biotechnology Information (NCBI).
Subspecies are resolved by determination of the closest available reference
using Mash. Virulence factors are detected with SRST2 in combination with the
Virulence Factor Database (VFDB). Metagenomics, especially when integrated into
predictive models, has made a significant contribution to risk assessment
investigations since it can answer questions related to risk assessment, such
as what pathogens are found in food and how they interact as well as how
environmental factors affect features of the foodborne pathogens such as
virulence and resistance<bold>82</bold>.</p><p >Despite its
potential and numerous advantages, metagenomics sequencing has hurdles
surrounding its applicability, efficiency, cost, and standardization. Shotgun
sequencing, for example, is incapable of discriminating between viable and dead
organisms. Interestingly, several wet-lab scientists and bioinformaticians are
increasingly providing solutions to these challenges<bold>98</bold>. To assess the
potential infection risk posed by Campylobacter, it is necessary to
employ techniques that ascertain viability since the viability of pathogens is
an essential parameter in food and water quality assessment<bold>99</bold>. Conventional
culture-based techniques, which rely on the ability of viable microbes to take
up nutrients and produce colonies in a culture medium, have been used for many
years, but these methods are both arduous and time-consuming<bold>100</bold>. For example, Campylobacter
spp. take a week or more to produce a positive detection result using the culture
method. In addition, the sensitivity of culture methods is low since they are
not always capable of detecting microbes in viable but nonculturable states,
even though their detection is necessary to prevent disease outbreaks<bold>101</bold>. </p><p >Various novel
viability assays such as dye-based assays, phage-based assays, testing of
cellular metabolism as well as the measurement of heat flow and ATP production
have emerged in the last twenty years<bold>102</bold>. Viability PCR or
vPCR has been widely employed, reviewed, and optimized as an efficient method
for discriminating viable from inactivated cells. The underlying principle of
vPCR is that it correlates viability with cell envelope permeability. Here,
microorganisms in a sample are incubated with a dye such as a propidium
monoazide (PMA). Following photo-activation, dye binds to exposed DNA and
interferes with the amplification during PCR. Inactivated or dead cells with
damaged membranes have their nucleic acids exposed to the dye. Once the dye-DNA
complex is photo-activated, the amplification of non-viable cells is blocked<bold>103</bold>. On the contrary,
viable cells having their cell membranes still intact exclude the dye, leading
to strong quantitative PCR (qPCR) signals in the presence of the dye<bold>104</bold>. Viability PCR has
been employed to study the viability of not just commonly studied bacteria but
also fastidious bacteria, spore-forming bacteria, protozoans, fungi, and even
viruses. This aggrandizes how efficient the technique is in distinguishing dead
microbial cells from viable cells and how useful it can be in microbial risk
assessment<bold>105</bold>.</p>
			</sec><sec>
			<title>INFECTIOUS DISEASE TRANSMISSION AND QUANTITATIVE MICROBIAL RISK ASSESSMENT MODELING</title>
				<p >Both infectious
disease transmission and quantitative microbial risk assessment modeling have
been employed to decipher the source and degree of infectious disease risk, the
role of various routes of transmission as well as possible control strategies<bold>106</bold>. Infectious disease
transmission modeling has been used for decades by infectious disease
epidemiologists to carry out epidemiological studies. One such modeling
framework is the susceptible–infectious–recovered, which models
person-to-person contact and infection transmission in a given population and
has been in use since the 1900s<bold>107</bold>.</p><p >Infectious disease
transmission models use mathematical equations to visualize the spread of
pathogens within a population. They can be used to determine the direction and
degree of disease outbreaks and generate information on factors that influence
disease transmission and the impact of the containment strategy<bold>108</bold>. In infectious
disease models, it is usually assumed that individuals infected with an
infectious disease are capable of spreading the disease to other individuals in
the population<bold>109</bold>. In order to understand
this process of transmission, infectious disease transmission models use
various variables representing the numbers of individuals of several different
attributes associated with infection in a population. Typically, these
attributes include susceptible, exposed, infected, and removed. In the
infectious disease transmission modeling, whether an individual is regarded as
infectious or otherwise must be considered<bold>110</bold>. In a population,
those who are infectious are those who are infected and could potentially
spread infectious agents to other individuals. In contrast, those who are not
infected but can acquire the infection are regarded as susceptible individuals
within the population<bold>106</bold>.</p><p >On the other hand,
individuals who associate with the infected individuals who might have been
infected but are not yet infectious are regarded as exposed, and lastly, those
who have recovered and are no longer infectious and are immune from
re-infection are referred to as removed. Being removed may mean such an
individual was killed by the infection or developed complete post-recovery
immunity. The underlying point is that removed individuals are incapable of
further transmitting the infection<bold>111</bold>. Mathematical
models that rely on the susceptible, infectious and removed attributes are
referred to as the Susceptible-Infectious-Removed (SIR) models. In SIR model,
the flow of infection typically starts from susceptible to removal. Individuals
usually start as susceptible, become infective at a given time, recover after a
certain infectious period, and thence become removed. This way, the possibility
of acquiring infection for a susceptible individual usually relies on the
status of individuals in the SIR model, which is the leading principle for the
classic non-linear dynamics within disease transmission. On the other hand, the
timing of removal following infection (the infectious duration) typically does
not depend on other individuals and their status<bold>112</bold>.</p><p >A simple SIR model
can be expanded to include additional attributes germane to the transmission
dynamics of a particular disease of interest. The attribute ‘exposed’ is often
included, resulting in a corresponding model referred to as Susceptible-Exposed-Infectious-Recovered
(SEIR) model. Equally, addition or alteration of attributes transition is
possible<bold>113</bold>. For example,
individuals may lose their acquired post-recovery immunity over time, resulting
in changing their status from the removed to the susceptible, thereby yielding
the Susceptible-Infectious-Recovered-Susceptible (SIRS) model<bold>114</bold>. Similarly, the
removed state can entirely be left out of the model if the infectious agent
under study does not trigger the production of any form of post-recovery
immunity, yielding Susceptible-Infectious-Susceptible (SIS) model<bold>115</bold>. </p><p >One disadvantage of
the basic SIR model is that it cannot discriminate whether an infected individual
develops symptoms, even though this could be an essential transmission factor<bold>109</bold>. For instance,
individuals infected with airborne respiratory pathogens are more likely to
spread the infection if they develop frequent coughing and sneezing symptoms.
Similarly, it is necessary to account for asymptomatic individuals for diseases
in which asymptomatic infection (carriage) is the fundamental transmission
driver, such as meningococcal or pneumococcal disease. Irrespective of the
model specification, individuals are primarily assigned to a group based on
specific health attributes, which could change from time to time. In the last
ten years, modelers have faced increasing hurdles, the most important of which
is the growing availability of genomic and other ‘omics’ data generated for
diagnostic and surveillance, which has reformed the field of risk assessment<bold>116</bold>. However, recent
advances in computer algorithms and machine learning technology offer
researchers an efficient alternative that overcomes these challenges<bold>117</bold>.</p>
			</sec><sec>
			<title>WGS, MACHINE LEARNING AND MICROBIAL RISK ASSESSMENT</title>
				<p >Establishing the
links between WGS or metagenomics data sets and specific risk indicators is
especially important. However, the complex nature of genomic data concerning
the number of microbial isolates remains a significant challenge, especially in
applying conventional statistical tools<bold>82</bold>. Most microbial
risk assessment models cannot discriminate strains in terms of their
differences in resistance and virulence. Interestingly, machine learning
technology and other novel models currently deployed in microbial risk
assessment can analyze large data sets while accurately predicting the risk/in
a population<bold>118</bold>. Machine learning
algorithms are developed and employed for risk assessment. Over time, these
algorithms are improved for better performance. These technologies can identify
a combination of factors that allows the prediction of risk outcomes, thereby
making risk assessment from big data sets more sensitive and reliable.
Additionally, conventional risk assessment models usually use intermediate
genetic interactions<bold>119</bold>.</p><p >On the other hand,
machine learning algorithms consider personal effects, which rely on
interactions between environmental and genetic factors. Machine learning
algorithms allow simultaneous prediction and interpretation using big data
sets. Consequently, it is possible to unveil a particular phenotype and predict
the presence of the protein from a sequence. With machine learning methods, it
is also possible to carry out a microbial risk assessment with the flexibility
to certain genetic acquired variations, which could favor the timely
identification of strains with novel resistance or virulence determinants<bold>118</bold>. The applications
of machine learning technology in genomics and as a placement for the classical
genome-wide association studies have proliferated in recent years. Far-reaching
disease indicators have been studied through their application to gene
expression data, where computer algorithms learn to discriminate between
various disease phenotypes. Other successful applications of machine learning
algorithms in health and disease include a better understanding of the
relationship between patient genotypes, gene-expression-related phenotypes, and
patient outcomes in cancer research, as well as the discovery of regions in
bacterial genomes code for antibiotic resistance. The application of machine
learning algorithms in risk assessment using WGS data has been described. WGS
data becomes a powerful tool for microbial source tracking and risk assessment
when analyzed using an appropriate source tracking algorithm.</p>
			</sec><sec>
			<title>CONCLUSION</title>
				<p >In
conclusion, the evidence reviewed here provides valuable information on the
various medically necessary Campylobacter spp, their mechanism of
resistance, important reservoirs, and most importantly, how advanced molecular
techniques are deployed in microbial risk assessment and source tracking. In
particular, the limitations of conventional methods, which include time-consumption,
poor sensitivity and specificity on the one hand, and the superiority of WGS
and machine learning technology, which include high reliability and robustness,
on the other hand, have been explored. The application of machine learning and
NGS technologies offer massive potential since they can be deployed in
combination to track sources of outbreaks and predict risks. If timely
deployed, they could help tackle outbreaks from their sources, thereby
minimizing casualties and other impacts. Noteworthy, these technologies,
despite their numerous advantages, their deployment in resource-limited
settings is constrained by factors such as lack of expertise and the cost.</p>
			</sec><sec>
			<title>ACKNOWLEDGMENT</title>
				<p >We acknowledge the
contributions of anonymous reviewers whose useful comments improve the quality
of this article. This research did not obtain external funding.</p>
			</sec><sec>
			<title>AUTHORS’ CONTRIBUTION</title>
				<p ><bold>Bashar Haruna Gulumbe</bold>: conceptualization, drafting of the manuscript, revision of the
manuscript, and approval of the final draft. <bold>Abbas Yusuf Bazata</bold>: conceptualization,
drafting of the manuscript, revision of the manuscript, and approval of the
final draft. <bold>Musbahu Abdullahi Bagwai</bold>: drafting of the manuscript,
revision of the manuscript, and approval of the final draft.</p>
			</sec><sec>
			<title>DATA AVAILABILITY</title>
				<p >None.</p>
			</sec><sec>
			<title>CONFLICT OF INTEREST</title>
				<p >The
authors have no conflict of interest to declare.</p>
			</sec><sec>
			<title>REFERENCES</title>
				<p >1.
Igwaran A, Okoh AI. Human campylobacteriosis: A public health concern of
global importance. Heliyon. 2019;5(11):e02814. doi:10.1016/j.heliyon.2019.e02814</p><p >2.
Aslam B, Wang W, Arshad MI, Khurshid M, Muzammil S, Rasool MH, et al. Antibiotic
resistance: a rundown of a global crisis. Infect Drug Resist. 2018;11:1645-58.
doi:10.2147/idr.s173867</p><p >3.
Manyi-Loh C, Mamphweli S, Meyer E, Okoh A. Antibiotic Use in Agriculture
and Its Consequential Resistance in Environmental Sources: Potential Public
Health Implications. Molecules. 2018;23(4):795. doi:10.3390/molecules23040795</p><p >4.
Facciolà A, Riso R, Avventuroso E, Visalli G, Delia SA, Laganà P. Campylobacter:
from microbiology to prevention. J Prev Med Hyg. 2017;58(2):E79-92.</p><p >5.
Rodrigues C, Cunha MÂ. Assessment of the microbiological quality of
recreational waters: indicators and methods. Euro-Mediterr J Environ Integr.
2017;2:25. doi:10.1007/s41207-017-0035-8</p><p >6.
Li E, Saleem F, Edge TA, Schellhorn HE. Biological Indicators for Fecal
Pollution Detection and Source Tracking: A Review. Processes. 2021;9(11):2058.
doi:10.3390/pr9112058</p><p >7.
Teixeira P, Dias D, Costa S, Brown B, Silva S, Valério E. Bacteroides
spp. and traditional fecal indicator bacteria in water quality assessment - An
integrated approach for hydric resources management in urban centers. J Environ
Manage. 2020;271:110989. doi:10.1016/j.jenvman.2020.110989</p><p >8.
Ahmed W, Hamilton K, Toze S, Cook S, Page D. A review on microbial
contaminants in stormwater runoff and outfalls: Potential health risks and
mitigation strategies. Sci Total Environ. 2019;692:1304-21. doi:10.1016/j.scitotenv.2019.07.055</p><p >9.
Edge TA, Hill S, Seto P, Marsalek J. Library-dependent and
library-independent microbial source tracking to identify spatial variation in
faecal contamination sources along a Lake Ontario beach (Ontario, Canada).
Water Sci Technol. 2010;62(3):719-27. doi:10.2166/wst.2010.335</p><p >10.
Vadde KK, McCarthy AJ, Rong R, Sekar R. Quantification of Microbial
Source Tracking and Pathogenic Bacterial Markers in Water and Sediments of
Tiaoxi River (Taihu Watershed). Front Microbiol. 2019;10:699. doi:10.3389/fmicb.2019.00699</p><p >11.
Schuppler M, Lötzsch K, Waidmann M, Autenrieth IB. An abundance of
Escherichia coli is harbored by the mucosa-associated bacterial flora of
interleukin-2-deficient mice. Infect Immun. 2004;72(4):1983-90. doi:10.1128/iai.72.4.1983-1990.2004</p><p >12.
Liu R, Chiang MHY, Lun CHI, Qian PY, Lau SCK. Host-specific 16S rRNA
gene markers of Bacteroidales for source tracking of fecal pollution in the
subtropical coastal seawater of Hong Kong. Water Res. 2010;44(20):6164-74. doi:10.1016/j.watres.2010.07.035</p><p >13.
Green HC, Dick LK, Gilpin B, Samadpour M, Field KG. Genetic markers for
rapid PCR-based identification of gull, Canada goose, duck, and chicken fecal
contamination in water. Appl Environ Microbiol. 2012;78(2):503–10. doi:10.1128/aem.05734-11</p><p >14.
Odagiri M, Schriewer A, Hanley K, Wuertz S, Misra PR, Panigrahi P, et
al. Validation of Bacteroidales quantitative PCR assays targeting human and
animal fecal contamination in the public and domestic domains in India. Sci
Total Environ. 2015;502:462–70. doi:10.1016/j.scitotenv.2014.09.040</p><p >15.
Boehm AB, Wang D, Ercumen A, She M, Harris AR, Shanks OC, et al.
Occurrence of host-associated fecal markers on child hands, household soil, and
drinking water in rural Bangladeshi households. Environ Sci Technol Lett. 2016;3(11):393–8.
doi:10.1021/acs.estlett.6b00382</p><p >16.
Shanks OC, Atikovic E, Blackwood AD, Lu J, Noble RT, Domingo JS, et al. Quantitative
PCR for detection and enumeration of genetic markers of bovine fecal pollution.
Appl Environ Microbiol. 2008;74(3):745-52. doi:10.1128/aem.01843-07</p><p >17.
Kraemer SA, Ramachandran A, Perron GG. Antibiotic Pollution in the
Environment: From Microbial Ecology to Public Policy. Microorganisms.
2019;7(6):180. doi:10.3390/microorganisms7060180</p><p >18.
Choi Y, Oda E, Waldman O, Sajda T, Beck C, Oh I. Next-Generation
Sequencing for Pathogen Identification in Infected Foot Ulcers. Foot Ankle
Orthop. 2021;6(3):24730114211026933. doi:10.1177/24730114211026933</p><p >19.
Couto N, Schuele L, Raangs EC, Machado MP, Mendes CI, Jesus TF, et al. Critical
steps in clinical shotgun metagenomics for the concomitant detection and typing
of microbial pathogens. Sci Rep. 2018;8(1):13767. doi:10.1038/s41598-018-31873-w</p><p >20.
Buytaers FE, Saltykova A, Denayer S, Verhaegen B, Vanneste K, Roosens
NHC, et al. A Practical Method to Implement Strain-Level Metagenomics-Based
Foodborne Outbreak Investigation and Source Tracking in Routine.Microorganisms.
2020;8(8):1191. doi:10.3390/microorganisms8081191</p><p >21.
Zhang L, Chen F, Zeng Z, Xu M, Sun F, Yang L, et al. Advances in
Metagenomics and Its Application in Environmental Microorganisms. Front
Microbiol. 2021;12:766364. doi:10.3389/fmicb.2021.766364</p><p >22.
Donia MS, Cimermancic P, Schulze CJ, Brown LCW, Martin J, Mitreva M, et
al. A systematic analysis of biosynthetic gene clusters in the human microbiome
reveals a common family of antibiotics. Cell. 2014;158(6):1402–14. doi:10.1016/j.cell.2014.08.032</p><p >23.
Norman JM, Handley SA, Baldridge MT, Droit L, Liu CY, Keller BC, et al.
Disease-specific alterations in the enteric virome in inflammatory bowel
disease. Cell. 2015;160(3):447–60. doi:10.1016/j.cell.2015.01.002</p><p >24.
Loman NJ, Constantinidou C, Christner M, Rohde H, Chan JZM, Quick J, et
al. A culture-independent sequence-based metagenomics approach to the investigation
of an outbreak of Shiga-toxigenic Escherichia coli O104:H4. JAMA. 2013;309(14):1502–10.
doi:10.1001/jama.2013.3231</p><p >25.
Cocolin L, Mataragas M, Bourdichon F, Doulgeraki A, Pilet MF, Jagadeesan
B, et al. Next generation microbiological risk assessment meta-omics : The next need for integration. Int J Food Microbiol. 2018;287:10-7.
doi:10.1016/j.ijfoodmicro.2017.11.008</p><p >26.
Veron M, Chatelain R. Taxonomic study of the genus Campylobacter Sebald
and Veron and designation of the neotype strain for the type species,
Campylobacter fetus (Smith and Taylor) Sebald and Veron. Int J Syst Evol Microbiol.
1973;23(2):122–34. doi:10.1099/00207713-23-2-122</p><p >27.
Whitehouse CA, Zhao S, Tate H. Antimicrobial Resistance in Campylobacter
Species : Mechanisms and Genomic Epidemiology. Adv Appl Microbiol.
2018;103:1-47. doi:10.1016/bs.aambs.2018.01.001</p><p >28.
Dasti JI, Tareen AM, Lugert R, Zautner AE, Gross U. Campylobacter
jejuni: A brief overview on pathogenicity-associated factors and
disease-mediating mechanisms. Int J Med Microbiol. 2010;300(4):205-11. doi:10.1016/j.ijmm.2009.07.002</p><p >29.
Iraola G, Pérez R, Naya H, Paolicchi F, Pastor E, Valenzuela S, et al.
Genomic Evidence for the Emergence and Evolution of Pathogenicity and Niche
Preferences in the Genus Campylobacter. Genome Biol Evol. 2014;6(9):2392–405.
doi:10.1093/gbe/evu195</p><p >30.
Hatanaka N, Shimizu A, Somroop S, Li Y, Asakura M, Nagita A, et al. High
prevalence of Campylobacter ureolyticus in stool specimens of children with
diarrhea in Japan. Jpn J Infect Dis. 2017;70(4):455–7. doi:10.7883/yoken.jjid.2016.428</p><p >31.
Chen Y, Mukherjee S, Hoffmann M, Kotewicz ML, Young S, Abbott J, et al.
Whole-genome sequencing of gentamicin-resistant Campylobacter coli isolated
from U.S. retail meats reveals novel plasmid-mediated aminoglycoside resistance
genes. Antimicrob Agents Chemother. 2013;57(11):5398–405. doi:10.1128/aac.00669-13</p><p >32.
Gibreel A, Wetsch NM, Taylor DE. Contribution of the CmeABC efflux pump
to macrolide and tetracycline resistance in Campylobacter jejuni. Antimicrob
Agents Chemother. 2007;51(9):3212–16. doi:10.1128/aac.01592-06</p><p >33.
Shobo CO, Bester LA, Baijnath S, Somboro AM, Peer AKCC, Essack SY.
Original Article Antibiotic resistance profiles of Campylobacter species in the
South Africa private health care sector. J Infect Dev Ctries.
2016;10(11):1214-21. doi:10.3855/jidc.8165</p><p >34.
Acke E. Campylobacteriosis in dogs and cats: a review. N Z Vet J. 2018;66(5):221-8.
doi:10.1080/00480169.2018.1475268</p><p >35.
Mourkas E, Florez-Cuadrado D, Pascoe B, Calland JK, Bayliss SC, Mageiros
L, et al. Gene pool transmission of multidrug resistance among Campylobacter
from livestock, sewage and human disease. Environ Microbiol.
2019;21(12):4597-613. doi:10.1111/1462-2920.14760</p><p >36.
Tyson GH, McDermott PF, Li C, Chen Y, Tadesse DA, Mukherjee S, et al.
WGS accurately predicts antimicrobial resistance in Escherichia coli. J
Antimicrob Chemother. 2015;70(10):2763–9. doi:10.1093/jac/dkv186</p><p >37.
Rosner BM, Schielke A, Didelot X, Kops F, Breidenbach J, Willrich N, et
al. A combined case-control and molecular source attribution study of human
Campylobacter infections in Germany, 2011–2014. Sci Rep. 2017;7(1):5139. doi:10.1038/s41598-017-05227-x</p><p >38.
Chukwu MO, Luther A, Abia K, Ubomba-jaswa E, Obi L, Dewar JB.
Characterization and Phylogenetic Analysis of Campylobacter Species Isolated
from Paediatric Stool and Water Samples in the Northwest Province, South
Africa. Int J Environ Res Public Health. 2019;16(12):2205. doi:10.3390/ijerph16122205</p><p >39.
Bourke B, Chan VL, Sherman P. Campylobacter upsaliensis: Waiting in the
wings. Clin Microbiol Rev. 1998;11(3):440–9. doi:10.1128/cmr.11.3.440</p><p >40.
Abril C, Brodard I, Perreten V. Located within a Transferable
Pathogenicity Island in Campylobacter fetus subsp. fetus. Antimicrob Agents
Chemother. 2010;54(7):3052-5. doi:10.1128/aac.00304-10</p><p >41.
Wagenaar JA, van Bergen MA, Blaser MJ, Tauxe RV, Newell DG, van Putten
JP. Campylobacter fetus infections in humans: Exposure and disease. Clin Infect
Dis. 2014;58(11):1579–86. doi:10.1093/cid/ciu085</p><p >42.
Roe DE, Weinberg A, Roberts MC. Mobile rRNA methylase genes in
Campylobacter (Wolinella) rectus. J Antimicrob Chemother. 1995;36(4):738–40.
doi:10.1093/jac/36.4.738</p><p >43.
Mahlen SD, Clarridge JE. Oral Abscess Caused by Campylobacter rectus:
Case Report and Literature Review ᰔ. J Clin Microbiol. 2009;47(3):848-51. doi:10.1128/jcm.01590-08</p><p >44.
Man SM. The clinical importance of emerging Campylobacter species. Nat
Rev Gastroenterol Hepatol. 2011;8(12):669-85. doi:10.1038/nrgastro.2011.191</p><p >45.
Laatu M, Rautelin H, Hänninen ML. Susceptibility of Campylobacter hyointestinalis
subsp. hyointestinalis to antimicrobial agents and characterization of
quinolone-resistant strains. J Antimicrob Chemother. 2005;55(2):182-7. doi:10.1093/jac/dkh537</p><p >46.
Iovine NM. Resistance mechanisms in Campylobacter jejuni. Virulence.
2013;4(3):230-40. doi:10.4161/viru.23753</p><p >47.
Taylor DE, Courvalin P. Mechanisms of antibiotic resistance in
Campylobacter species. Antimicrob Agents Chemother. 1988;32(8):1107–12. doi:10.1128/aac.32.8.1107</p><p >48.
Wieczorek K, Osek J. Antimicrobial resistance mechanisms among
Campylobacter. Biomed Res Int. 2013;2013:340605. doi:10.1155/2013/340605</p><p >49.
Munita JM, Arias CA. Mechanisms of Antibiotic Resistance. Microbiol Spectr.
2016;4(2):10.1128/microbiolspec.VMBF-0016-2015. doi:10.1128/microbiolspec.vmbf-0016-2015</p><p >50.
Hamilton AJ, Stagnitti F, Premier R, Boland AM, Hale G. Quantitative
microbial risk assessment models for consumption of raw vegetables irrigated
with reclaimed water. Appl Environ Microbiol. 2006;72(5):3284-90. doi:10.1128/aem.72.5.3284-3290.2006</p><p >51.
Eisenberg JNS, Lei X, Hubbard AH, Brookhart MA, Colford JM. The role of
disease transmission and conferred immunity in outbreaks: Analysis of the 1993
Cryptosporidium outbreak in Milwaukee, Wisconsin. Am J Epidemiol.
2005;161(1):62–72. doi:10.1093/aje/kwi005</p><p >52.
Eisenberg JNS, Brookhart MA, Rice G, Brown M, Colford JM. Disease
transmission models for public health decision making: Analysis of epidemic and
endemic conditions caused by waterborne pathogens. Environ Health Perspect.
2002;110(8):783–90. doi:10.1289/ehp.02110783</p><p >53.
Brouwer AF, Masters NB, Eisenberg JNS. Quantitative Microbial Risk
Assessment and Infectious Disease Transmission Modeling of Waterborne Enteric
Pathogen. Curr Environ Health Rep. 2019;5(2):293-304. doi:10.1007/s40572-018-0196-x</p><p >54.
Germovsek E, Barker CI, Sharland M. What do I need to know about
aminoglycoside antibiotics? Arch Dis Child Educ Pract Ed. 2017;102(2):89-93.
doi:10.1136/archdischild-2015-309069</p><p >55.
Schwarz S, Shen J, Kadlec K, Wang Y, Michael GB, Feßler AT, et al.
Lincosamides, Streptogramins, Phenicols, and Pleuromutilins: Mode of Action and
Mechanisms of Resistance. Cold Spring Harb Perspect Med. 2016;6(11):a027037.
doi:10.1101/cshperspect.a027037</p><p >56.
Roberts MC. Update on macrolide-lincosamide-streptogramin, ketolide, and
oxazolidinone resistance genes. FEMS Microbiol Lett. 2008;282(2):147-59. doi:10.1111/j.1574-6968.2008.01145.x</p><p >57.
Pham TDM, Ziora ZM, Blaskovich MAT. Quinolone antibiotics. Medchemcomm.
2019;10(10):1719-39. doi:10.1039/c9md00120d</p><p >58.
Pulicharla R, Hegde K, Brar SK, Surampalli RY. Tetracyclines metal
complexation: Significance and fate of mutual existence in the environment.
Environ Pollut. 2017;221:1-14. doi:10.1016/j.envpol.2016.12.017</p><p >59.
Abdi-Hachesoo B, Khoshbakht R, Sharifiyazdi H, Tabatabaei M,
Hosseinzadeh S, Asasi K. Tetracycline Resistance Genes in Campylobacter jejuni
and C. coli Isolated from Poultry Carcasses. Jundishapur J Microbiol. 2014;7(9):e12129.
doi:10.5812/jjm.12129</p><p >60.
Bush K, Bradford PA. β-Lactams and β-Lactamase Inhibitors: An Overview.
Cold Spring Harb Perspect Med. 2016;6(8):a025247. doi: https://doi.org/10.1101/cshperspect.a025247</p><p >61.
Chandrasekaran S, Jiang SC. A dose response model for quantifying the
infection risk of antibiotic-resistant bacteria. Sci Rep. 2019;9(1):17093. doi:10.1038/s41598-019-52947-3</p><p >62.
Haas CN. Microbial dose response modeling: past, present, and future. Environ
Sci Technol. 2015;49(3):1245-59. doi:10.1021/es504422q</p><p >63.
Nauta MJ. Modelling bacterial growth in quantitative microbiological
risk assessment: is it possible? Int J Food Microbiol. 2002;73(2-3):297-304.
doi:10.1016/s0168-1605(01)00664-x</p><p >64.
Ahmed Z, Mohamed K, Zeeshan S, Dong X. Artificial intelligence with
multi-functional machine learning platform development for better healthcare
and precision medicine. Database. 2020;2020:baaa010. doi:10.1093/database/baaa010</p><p >65.
Weir MH, Mitchell J, Flynn W, Pope JM. Development of a microbial dose
response visualization and modelling application for QMRA modelers and educators.
Environ Model Softw. 2017;88:74-83. doi:10.1016/j.envsoft.2016.11.011</p><p >66.
Schijven JF, Teunis PFM, Rutjes SA, Bouwknegt M, Husman AMdR. QMRAspot: a tool for Quantitative Microbial Risk
Assessment from surface water to potable water. Water Res. 2011;45(17):5564-76.
doi:10.1016/j.watres.2011.08.024</p><p >67.
Chen Y, Dennis SB, Hartnett E, Paoli G, Pouillot R, Ruthman T, et al. FDA-iRISK--a
comparative risk assessment system for evaluating and ranking food-hazard
pairs: case studies on microbial hazards. J Food Prot. 2013;76(3):376-85. doi:10.4315/0362-028x.jfp-12-372</p><p >68.
Ercolini D. High-throughput sequencing and metagenomics: moving forward
in the culture-independent analysis of food microbial ecology. Appl Environ
Microbiol. 2013;79(10):3148-55. doi:10.1128/aem.00256-13</p><p >69.
Sharpton TJ. An introduction to the analysis of shotgun metagenomic data.
Front Plant Sci. 2014;5:209. doi:10.3389/fpls.2014.00209</p><p >70.
Tengh F, Nair SSD, Zhu P, Li S, Huang S, Li X, et al. Impact of DNA extraction
method and targeted 16S-rRNA hypervariable region on oral microbiota profiling.
Sci Rep. 2018;8(1):16321. doi:10.1038/s41598-018-34294-x</p><p >71.
Durazzi F, Sala C, Castellani G, Manfreda G, Remondini D, De Cesare A. Comparison
between 16S rRNA and shotgun sequencing data for the taxonomic characterization
of the gut microbiota. Sci Rep. 2021;11(1):3030. doi:10.1038/s41598-021-82726-y</p><p >72.
Vecherskii MV, Semenov MV, Lisenkova AA, Stepankov AA. Metagenomics: A
New Direction in Ecology. Biol Bull Russ Acad Sci. 2021;48:S107-17. doi:10.1134/S1062359022010150</p><p >73.
Dai D, Rhoads WJ, Edwards MA, Pruden A. Shotgun Metagenomics Reveals
Taxonomic and Functional Shifts in Hot Water Microbiome Due to Temperature
Setting and Stagnation. Front Microbiol. 2018;9:2695. doi:10.3389/fmicb.2018.02695</p><p >74.
Chen H, Li Y, Sun W, Song L, Zuo R, Teng Y. Characterization and source
identi fi cation of antibiotic resistance genes in the sediments of an
interconnected river-lake system. Environ Int. 2020;137:105538. doi:10.1016/j.envint.2020.105538</p><p >75.
Mohiuddin MM, Salama Y, Schellhorn HE, Golding GB. Shotgun metagenomic
sequencing reveals freshwater beach sands as reservoir of bacterial pathogens.
Water Res. 2017;115:360-9. doi:10.1016/j.watres.2017.02.057</p><p >76.
Pérez-Cobas AE, Gomez-Valero L, Buchrieser C. Metagenomic approaches in
microbial ecology: an update on whole-genome and marker gene sequencing analyses.
Microb Genom. 2020;6(8):mgen000409. doi:10.1099/mgen.0.000409</p><p >77.
Clarridge JE. Impact of 16S rRNA gene sequence analysis for
identification of bacteria on clinical microbiology and infectious diseases.
Clin Microbiol Rev. 2004;17(4):840-62. doi:10.1128/cmr.17.4.840-862.2004</p><p >78.
Jovel J, Patterson J, Wang W, Hotte N, O’Keefe S, Mitchel T, et al. Characterization
of the Gut Microbiome Using 16S or Shotgun Metagenomics. Front Microbiol.
2016;7:459. doi:10.3389/fmicb.2016.00459</p><p >79.
Stewart MP, Langer R, Jensen KF. Intracellular Delivery by Membrane
Disruption: Mechanisms, Strategies, and Concepts. Chem Rev.
2018;118(16):7409-531. doi:10.1021/acs.chemrev.7b00678</p><p >80.
Awasthi MK, Ravindran B, Sarsaiya S, Chen H, Wainaina S, Singh E, et al.
Metagenomics for taxonomy profiling: tools and approaches. Bioengineered.
2020;11(1):356-74. doi:10.1080/21655979.2020.1736238</p><p >81.
Grützke J, Gwida M, Deneke C, Brendebach H, Projahn M, Schattschneider
A, et al. Direct identification and molecular characterization of zoonotic
hazards in raw milk by metagenomics using Brucella as a model pathogen. Microb
Genom. 2021;7(5):000552. doi:10.1099/mgen.0.000552</p><p >82.
EFSA Panel on Biological Hazards (EFSA BIOHAZ Panel), Koutsoumanis K,
Allende A, Alvarez-Ordóñez A, Bolton D, Bover-Cid S, et al. Whole genome
sequencing and metagenomics for outbreak investigation, source attribution and
risk assessment of food-borne microorganisms. EFSA J. 2019;17(12):e05898. doi:10.2903/j.efsa.2019.5898</p><p >83.
Priyanka B, Patil RK, Dwarakanath S. A review on detection methods used
for foodborne pathogens. Indian J Med Res. 2016;144(3):327-38. doi:10.4103/0971-5916.198677</p><p >84.
Uelze L, Grützke J, Borowiak M, Hammerl JA, Juraschek K, Deneke C, et
al. Typing methods based on whole genome sequencing data. One Health Outlook.
2020;2:3. doi:10.1186/s42522-020-0010-1</p><p >85.
Underwood AP, Dallman T, Thomson NR, Williams M, Harker K, Perry N, et
al. Public health value of next-generation DNA sequencing of enterohemorrhagic
Escherichia coli isolates from an outbreak. J Clin Microbiol. 2013;51(1):232–7.
doi:10.1128/jcm.01696-12</p><p >86.
Hoffmann M, Luo Y, Monday SR, Gonzalez-Escalona N, Ottesen AR, Muruvanda
T, et al. Tracing origins of the Salmonella Bareilly strain causing a
food-borne outbreak in the united states. J Infect Dis. 2016;213(4):502–8. doi:10.1093/infdis/jiv297</p><p >87.
Kleta S, Hammerl JA, Dieckmann R, Malorny B, Borowiak M, Halbedel S, et
al. Molecular tracing to find source of protracted invasive listeriosis
outbreak, southern Germany, 2012–2016. Emerg Infect Dis. 2017;23(10):1680–3.
doi:10.3201/eid2310.161623</p><p >88.
Allard MW, Strain E, Melka D, Buning K, Musser SM, Brown EW, et al. The
practical value of food pathogen traceability through building a wholegenome
sequencing network and database. J Clin Microbiol. 2016;54(8):1975–83. doi:10.1128/jcm.00081-16</p><p >89.
Rantsiou K, Kathariou S, Winkler A, Skandamis P, Saint-Cyr MJ,
Rouzeau-Szynalski K, et al. Next generation microbiological risk assessment:
opportunities of whole genome sequencing (WGS) for foodborne pathogen
surveillance, source tracking and risk assessment. Int J Food Microbiol.
2018;287:3-9. doi:10.1016/j.ijfoodmicro.2017.11.007</p><p >90.
Besser JM, Carleton HA, Trees E, Stroika SG, Hise K, Wise M, et al. Interpretation
of Whole-Genome Sequencing for Enteric Disease Surveillance and Outbreak
Investigation. Foodborne Pathog Dis. 2019;16(7):504-12. doi:10.1089/fpd.2019.2650</p><p >91.
Stein RA, Chirilã M. Routes of Transmission in the Food Chain. Foodborne
Dis. 2017;65-13. doi:10.1016/B978-0-12-385007-2.00003-6</p><p >92.
Afshinnekoo E, Chou C, Alexander N, Ahsanuddin S, Schuetz AN, Mason CE. Precision
Metagenomics: Rapid Metagenomic Analyses for Infectious Disease Diagnostics and
Public Health Surveillance. J Biomol Tech. 2017;28(1):40-5. doi:10.7171/jbt.17-2801-007</p><p >93.
Buytaers FE, Saltykova A, Mattheus W, Verhaegen B, Roosens NHC, Vanneste
K, et al. Application of a strain-level shotgun metagenomics approach on food
samples: resolution of the source of a Salmonella food-borne outbreak. Microb Genome.
2021;7(4):000547. doi:10.1099/mgen.0.000547</p><p >94.
Piombo E, Abdelfattah A, Droby S, Wisniewski M, Spadaro D, Schena L. Metagenomics
Approaches for the Detection and Surveillance of Emerging and Recurrent Plant
Pathogens. Microorganisms. 2021;9(1):188. doi:10.3390/microorganisms9010188</p><p >95.
Larsson DGJ, Flach CF. Antibiotic resistance in the environment. Nat Rev
Microbiol. 2022;20(5):257-69. doi:10.1038/s41579-021-00649-x</p><p >96.
Höper D, Grützke J, Brinkmann A, Mossong J, Matamoros S, Ellis RJ, et
al. Proficiency Testing of Metagenomics-Based Detection of Food-Borne Pathogens
Using a Complex Artificial Sequencing Dataset. Front Microbiol. 2020;11:575377.
doi:10.3389/fmicb.2020.575377</p><p >97.
Grützke J, Malorny B, Hammerl JA, Busch A, Tausch SH, Tomaso H, et al.
Fishing in the Soup – Pathogen Detection in Food Safety Using Metabarcoding and
Metagenomic Sequencing. Front Microbiol. 2019;10:1805. doi:10.3389/fmicb.2019.01805</p><p >98.
Bharucha T, Oeser C, Balloux F, Brown JR, Carbo EC, Charlett A, et al. STROBE-metagenomics:
a STROBE extension statement to guide the reporting of metagenomics studies.
Lancet Infect Dis. 2020;20(10):e251-60. doi:10.1016/s1473-3099(20)30199-7</p><p >99.
Lazou TP, Gelasakis AI, Chaintoutis SC, Iossifidou EG, Dovas CI. Method-Dependent
Implications in Foodborne Pathogen Quantification: The Case of Campylobacter
coli Survival on Meat as Comparatively Assessed by Colony Count and Viability
PCR. Front Microbiol. 2021;12:604933. doi:10.3389/fmicb.2021.604933</p><p >100. Lagier JC, Edouard S, Pagnier I, Mediannikov O,
Drancourt M, Raoult D. Current and past strategies for bacterial culture in
clinical microbiology. Clin Microbiol Rev. 2015;28(1):208-36. doi:10.1128/cmr.00110-14</p><p >101. Liu Y, Gilchrist A, Zhang J, Li XF. Detection of
viable but nonculturable Escherichia coli O157:H7 bacteria in drinking water
and river water. Appl Enciron Microbiol. 2008;74(5):1502-7. doi:10.1128/aem.02125-07</p><p >102. Schofield DA, Sharp NJ, Westwater C. Phage-based
platforms for the clinical detection of human bacterial pathogens. Bacteriophage.
2012;2(2):105-283. doi:10.4161/bact.19274</p><p >103. Cangelosi G, Meschke JS. Dead or alive:
molecular assessment of microbial viability. Appl Environ Microbiol. 2014;80(19):5884-91.
doi:10.1128/aem.01763-14</p><p >104. Zeng D, Chen Z, Jiang Y, Xue F, Li B. Advances
and Challenges in Viability Detection of Foodborne Pathogens. Front Microbiol.
2016;7:1833. doi:10.3389/fmicb.2016.01833</p><p >105. Cancino-Faure B, Fisa R, Alcover MM,
Jimenez-Marco T, Riera C. Detection and Quantification of Viable and Nonviable
Trypanosoma cruzi Parasites by a Propidium Monoazide Real-Time Polymerase Chain
Reaction Assay. Am J Trop Med Hyg. 2016;94(6):1282-9. doi:10.4269/ajtmh.15-0693</p><p >106. van Seventer JM, Hochberg NS. Principles of
Infectious Diseases: Transmission, Diagnosis, Prevention, and Control. Int
Encycl Public Health. 2017;22-39. doi:10.1016/B978-0-12-803678-5.00516-6</p><p >107. Yadav SK, Akhter Y. Statistical Modeling for the
Prediction of Infectious Disease Dissemination With Special Reference to
COVID-19 Spread. Front Public Health. 2021;9:645405. doi:10.3389/fpubh.2021.645405</p><p >108. Siettos CI, Russo L. Mathematical modeling of
infectious disease dynamics. Virulence. 2013;4(4):295-306. doi:10.4161/viru.24041</p><p >109. Cooper I, Mondal A, Antonopoulos CG. A SIR model
assumption for the spread of COVID-19 in different communities. Chaos Solitons
Fractals. 2020;139:110057. doi:10.1016/j.chaos.2020.110057</p><p >110. van den Driessche P. Reproduction numbers of
infectious disease models. Infect Dis Model. 2017;2(3):288-303. doi:10.1016/j.idm.2017.06.002</p><p >111. Cucinotta D, Vanelli M. WHO Declares COVID-19 a
Pandemic. Acta Biomed. 2020;91(1):157-60. doi:10.23750/abm.v91i1.9397</p><p >112. Liu T, Bai Y, Du M, Gao Y, Liu Y. Susceptible-Infected-Removed
Mathematical Model under Deep Learning in Hospital Infection Control of Novel
Coronavirus Pneumonia. J Healthc Eng. 2021;2021:1535046. doi:10.1155/2021/1535046</p><p >113. Abou-Ismail A. Compartmental Models of the
COVID-19 Pandemic for Physicians and Physician-Scientists. SN Compr Clin Med.
2020;2(7):852-8. doi:10.1007/s42399-020-00330-z</p><p >114. Brauer F. Mathematical epidemiology: Past,
present, and future. Infect Dis Model. 2017;2(2):113-27. doi:10.1016/j.idm.2017.02.001</p><p >115. Nikolaou M. Ziegler and Nichols meet Kermack and
McKendrick: Parsimony in dynamic models for epidemiology. Comput Chem Eng.
2022;157:107615. doi:10.1016/j.compchemeng.2021.107615</p><p >116. Howard LM, Zhu Y, Griffin MR, Edwards KM,
Williams JV, Gil AI, et al. Nasopharyngeal Pneumococcal Density during
Asymptomatic Respiratory Virus Infection and Risk for Subsequent Acute
Respiratory Illness. Emerg Infect Dis. 2019;25(11):2040-7. doi:10.3201/eid2511.190157</p><p >117. London AJ. Artificial intelligence in medicine:
Overcoming or recapitulating structural challenges to improving patient care?
Cell Rep Med. 2022;3(5):100622. doi:10.1016/j.xcrm.2022.100622</p><p >118. Njage PMK, Henri C, Leekitcharoenphon P, Mistou
MY, Hendriksen RS, Hald T. Machine Learning Methods as a Tool for Predicting
Risk of Illness Applying Next-Generation Sequencing Data. Risk Anal.
2019;39(6):1397-413. doi:10.1111/risa.13239</p><p >119. Hedge J, Rokseth B. Applications of machine
learning methods for engineering risk assessment – A review. Safety Sci. 2020;122:104492.
doi:10.1016/j.ssci.2019.09.015</p><p >120.
Nicholls HL, John CR, Watson DS, Munroe PB, Barnes MR, Cabrera CP. Reaching
the End-Game for GWAS: Machine Learning Approaches for the Prioritization of
Complex Disease Loci. Front Genet. 2020;11:350 doi:10.3389/fgene.2020.00350</p>
			</sec></body>
  <back>
    <ack>
      <p>We acknowledge the contributions of anonymous reviewers whose useful comments improve the quality of this article. This research did not obtain external funding.</p>
    </ack>
  </back>
</article>